MSE
REGN icon

MUFG Securities EMEA’s Regeneron Pharmaceuticals REGN Stock Holding History

MUFG Securities EMEA’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2M Buy
17,132
+13,000
+315% +$9.95M 0.2% 86
2025
Q4 		$3.19M Buy
4,132
+2,182
+112% +$1.48M 0.04% 241
2025
Q3 		$1.1M Buy
1,950
+1,643
+535% +$929K 0.03% 236
2025
Q2 		$161K Buy
+307
New +$171K 0.01% 238
2022
Q4 		– Sell
-135
Closed -$93K – 175
2022
Q3 		$93K Hold
135
– – ﹤0.01% 123
2022
Q2 		$80K Hold
135
– – ﹤0.01% 107
2022
Q1 		$94K Hold
135
– – ﹤0.01% 127
2021
Q4 		$85K Hold
135
– – ﹤0.01% 169
2021
Q3 		$82K Sell
135
-645
-83% -$400K ﹤0.01% 270
2021
Q2 		$436K Sell
780
-2,100
-73% -$1.06M ﹤0.01% 265
2021
Q1 		$1.36M Buy
2,880
+1,700
+144% +$828K 0.01% 289
2020
Q4 		$570K Buy
1,180
+559
+90% +$302K ﹤0.01% 338
2020
Q3 		$348K Buy
+621
New +$377K ﹤0.01% 351
2020
Q2 		– Sell
-1,280
Closed -$625K – 492
2020
Q1 		$625K Sell
1,280
-1,600
-56% -$660K 0.01% 354
2019
Q4 		$1.08M Buy
2,880
+2,004
+229% +$674K 0.01% 428
2019
Q3 		$243K Sell
876
-59,792
-99% -$17.7M ﹤0.01% 314
2019
Q2 		$19M Buy
60,668
+57,872
+2,070% +$19.3M 0.2% 86
2019
Q1 		$1.15M Sell
2,796
-2,690
-49% -$1.11M 0.01% 380
2018
Q4 		$2.05M Sell
5,486
-5,266
-49% -$1.93M 0.02% 251
2018
Q3 		$4.34M Buy
10,752
+1,721
+19% +$655K 0.06% 171
2018
Q2 		$3.12M Buy
9,031
+152
+2% +$47.5K 0.06% 173
2018
Q1 		$3.06M Sell
8,879
-43,739
-83% -$15.2M 0.06% 147
2017
Q4 		$19.8M Buy
52,618
+49,070
+1,383% +$19.9M 0.46% 51
2017
Q3 		$1.59M Buy
3,548
+1,625
+85% +$773K 0.06% 87
2017
Q2 		$944K Sell
1,923
-3,716
-66% -$1.63M 0.04% 63
2017
Q1 		$2.19M Buy
5,639
+3,802
+207% +$1.41M 0.11% 30
2016
Q4 		$674K Buy
1,837
+764
+71% +$291K 0.06% 25
2016
Q3 		$431K Buy
+1,073
New +$430K 0.39% 26

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

MUFG Securities EMEA's REGN Position: Q1 2026 in Review

MUFG Securities EMEA increased its Regeneron Pharmaceuticals (REGN) stake by 315% in Q1 2026, buying an estimated $9.95M and bringing the position to 17,132 shares worth $13.2M. The position accounts for 0.2% of the portfolio, ranked #86.

MUFG Securities EMEA first reported a position in REGN in Q3 2016 and has held it in 28 quarters since. The position peaked at $19.8M in Q4 2017. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • MUFG Securities EMEA held 17,132 shares of Regeneron Pharmaceuticals worth $13.2M as of Q1 2026.
  • MUFG Securities EMEA bought 13,000 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $9.95M.
  • Regeneron Pharmaceuticals made up 0.2% of MUFG Securities EMEA's portfolio in Q1 2026, its #86 holding.
  • MUFG Securities EMEA first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 28 quarters since.
  • MUFG Securities EMEA's Regeneron Pharmaceuticals position peaked at $19.8M in Q4 2017.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on MUFG Securities EMEA's 13F filing for Q1 2026, filed 11 May 2026.